Sulfasalazine: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk (DailyMed link) |
imported>David E. Volk m (→External Links) |
||
Line 35: | Line 35: | ||
== External Links == | == External Links == | ||
* {{DailyMed}} | * {{DailyMed}} | ||
* {{MedMaster}} | |||
* {{DrugBank}} |
Revision as of 12:28, 5 March 2008
Sulfasalazine (SSZ), also called sulphasalazine and sulfasalazin, is a drug used in the treatment of inflammatory bowel disease. Its official IUPAC name is (3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid and its chemical formula is C18H14N4O5S . Its effects are thought to be due to its breakdown product, 5-aminosalicylic acid (see mesalamine), which is released into the colon. It is also used to treat rheumatoid arthritis
brand names
- Accucol
- Alti-Sulfasalazine
- Asulfidine
- Azlufidine EN-Tabs
- Azopyrin
- Azopyrine
- Azulfidine
- Azulfidine EN-Tabs
- Benzosulfa
- Colo-Pleon
- PMS-Sulfasalazine
- Pms-Sulfasalazine E.C.
- Reupirin
- Rorasul
- S.A.S. Enteric-500
- Salazopiridazin
- Salazopyridin
- Salazopyrin
- Salazopyrin EN-Tabs
- Salazosulfapyridin
- Salazosulfapyridine
- Salicylazosulfapyridine
- Salisulf
- Sulcolon
- W-T Sasp Oral
External Links
- Sulfasalazine - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank